NEW YORK (GenomeWeb) – As part of an effort to build a Small Cell Lung Cancer (SCLC) Consortium, National Cancer Institute announced that it intends to fund research that will support the development of new molecular diagnostics and screening approaches for populations at high risk of developing the disease.

The agency said that approved projects may receive up to $450,000 in annual direct costs for up to five years, with the total number of awards depending on National Institutes of Health appropriations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.